TITLE

Serotype markers in a Streptococcus agalactiae strain collection from Zimbabwe

AUTHOR(S)
Mavenyengwa, R. T.; Maeland, J. A.; Moyo, S. R.
PUB. DATE
October 2010
SOURCE
Indian Journal of Medical Microbiology;Oct2010, Vol. 28 Issue 4, p313
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: Group B streptococci (GBS) from Southern African areas have been less well characterized. Our objective was to study serotype and serovariant distribution of carrier GBS strains as part of a study of the epidemiology of GBS carriage in pregnant women from Zimbabwe. Materials and Methods: We studied GBS isolated from 121 healthy pregnant women living in Harare and surrounding areas, Zimbabwe. Capsular polysaccharide (CPS) testing for serotype determination and surface-anchored protein testing for serosubtype determination were done by gene-based serotyping (PCR), except for the proteins R3 and a novel protein called Z, which were detected by antibody-based methods. Results: Strains of the CPS types Ia (15.7%), Ib (11.6%), II (8.3%), III (38.8%), V (24.0%) and NT (1.7%) were detected along with the strain-variable proteins Cβ (15.7% of isolates), Cα (19.8%), Alp1 (epsilon-22.3%), Alp3 (5.0%), R4/Rib (46.3%), R3 (27.3%), Z (27.3%), and SAR5 (28.9%), which encodes the R5 protein. Up to four of the protein genes could be possessed or the gene product expressed by one and the same isolate. A total of 32 serovariants were detected. The findings assessed by us as most important were the very low prevalence of the gene Alp3 (Alp3 - 4.9%), high prevalence of R4 (Rib - 46.2%), the proteins R3 (27.3%), Z (27.3%), and of SAR5 (R5 - 28.9%). The low prevalence of Alp3, notably in GBS type V strains, differed from findings with CPS type V GBS from non-African areas. Bacteria of the various CPS types showed distinct CPS/protein-marker associations. Conclusion: The results are of importance in relation to regional variations of GBS phenotypes and genotypes and thus, of importance in planning and research in the context of future vaccine formulations.
ACCESSION #
55249688

 

Related Articles

  • Expression of Group B Protective Surface Protein (BPS) by Invasive and Colonizing Isolates of Group B Streptococci. Flores, Aurea; Chhatwal, G.; Hillier, Sharon; Baker, Carol; Ferrieri, Patricia // Current Microbiology;Dec2014, Vol. 69 Issue 6, p894 

    Group B protective surface protein (BPS) is expressed on the cell surface of some group B streptococcal (GBS) ( Streptococcus agalactiae) strains and adds to the identification by capsular polysaccharide (CPS), and c or R proteins. We investigated the prevalence of BPS among GBS clinical...

  • Identification and molecular characterization of a S. agalactiae strain lacking the capsular locus. Creti, R.; Imperi, M.; Pataracchia, M.; Alfarone, G.; Recchia, S.; Baldassarri, L. // European Journal of Clinical Microbiology & Infectious Diseases;Mar2012, Vol. 31 Issue 3, p233 

    During a national surveillance program on Group B streptococci (GBS) maternal carriage and neonatal infections, a GBS strain isolated from a pregnant woman's vagino-rectal swab was non typable by either serological or molecular methods. Further molecular characterization demonstrated that the...

  • Phenotypes, genotypes, serotypes and molecular epidemiology of erythromycin-resistant Streptococcus agalactiae in Italy. Francesco, M.; Caracciolo, S.; Gargiulo, F.; Manca, N. // European Journal of Clinical Microbiology & Infectious Diseases;Aug2012, Vol. 31 Issue 8, p1741 

    The purpose of this investigation was to analyse Streptococcus agalactiae (group B Streptococcus, GBS) isolates collected in Italy from vaginal and urine samples in respect to their clonality, distribution of virulence factors and antimicrobial resistance determinants. Three hundred and...

  • Identification and immunoreactivity of proteins released fromStreptococcus agalactiae. Fluegge, K.; Schweier, O.; Schiltz, E.; Batsford, S.; Berner, R. // European Journal of Clinical Microbiology & Infectious Diseases;Nov2004, Vol. 23 Issue 11, p818 

    The aim of the present study was to identify released proteins ofStreptococcus agalactiaeand to investigate their immunoreactivity with human sera to determine whether such proteins might be viable as carrier proteins in conjugate vaccines. Infections withS. agalactiaeare the leading cause of...

  • Antibacterial Activity of Selected Standard Strains of Lactic Acid Bacteria Producing Bacteriocins - Pilot Study. Bodaszewska-Lubas, Malgorzata; Brzychczy-Wloch, Monika; Gosiewski, Tomasz; Heczko, Piotr B. // Advances in Hygiene & Experimental Medicine / Postepy Higieny i ;2012, Vol. 66, p787 

    Introduction: In this paper, an attempt was made to evaluate the antibacterial potential of standard strains of lactic acid bacteria (LAB) producing bacteriocins of various classes, thus demonstrating various mechanisms of cell membrane damages against the Streptococcus agalactiae strains (Group...

  • The enhancement of biofilm formation in Group B streptococcal isolates at vaginal pH. Ho, Yueh-Ren; Li, Chien-Ming; Yu, Chen-Hsiang; Lin, Yuh-Jyh; Wu, Ching-Ming; Harn, I-Chen; Tang, Ming-Jer; Chen, Yi-Ting; Shen, Fang-Chi; Lu, Chien-Yi; Tsai, Tai-Chun; Wu, Jiunn-Jong // Medical Microbiology & Immunology;Apr2013, Vol. 202 Issue 2, p105 

    Group B streptococcus (GBS) is a common asymptomatic colonizer in acidic vagina of pregnant women and can transmit to newborns, causing neonatal pneumonia and meningitis. Biofilm formation is often associated with bacterial colonization and pathogenesis. Little is known about GBS biofilm and the...

  • Antigenic distribution of Streptococcus agalactiae isolates from pregnant women at Garankuwa hospital - South Africa. Chukwu, Martina O.; Mavenyengwa, Rooyen Tinago; Monyama, Charles M.; Bolukaoto, John Y.; Lebelo, Sogolo L.; Maloba, Motlatji R. B.; Nchabeleng, Maphoshane; Moyo, Sylvester Rogers // Germs;Dec2015, Vol. 5 Issue 4, p125 

    Introduction Streptococcus agalactiae (group B streptococcus; GBS) is globally recognised as one of the leading causes of neonatal sepsis and meningitis. It also causes adverse pregnancy outcomes such as stillbirth and miscarriages. Incidence of invasive disease is increasing in non-pregnant...

  • Genetic islands of Streptococcus agalactiae strains NEM316 and 2603VR and their presence in other Group B Streptococcal strains. Herbert, Mark A.; Beveridge, Catriona J.E.; McCormick, David; Aten, Emmelien; Jones, Nicola; Snyder, Lori A.S.; Saunders, Nigel J. // BMC Microbiology;2005, Vol. 5, p1 

    Background: Streptococcus agalactiae (Group B Streptococcus; GBS) is a major contributor to obstetric and neonatal bacterial sepsis. Serotype III strains cause the majority of late-onset sepsis and meningitis in babies, and thus appear to have an enhanced invasive capacity compared with the...

  • Carriage Rate of Group B Streptococci in Pregnant Women in Three Teaching Hospitals in Shiraz, Iran. Hassanzadeh, Parvin; Motamedifar, Mohammad; Gharaghani, Maral Namdari // Medical Principles & Practice;Mar2011, Vol. 20 Issue 3, p277 

    Objective: The main goal of this study was to assess differences in the vaginal flora of pregnant women and provide a detailed evaluation of vaginal swabs for the presence of group B streptococcus (GBS) and other organisms in three teaching hospitals in Shiraz, southwest of Iran. Subjects and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics